Fig. 4
From: LncRNA TDRKH-AS1 promotes breast cancer progression via the miR-134-5p/CREB1 axis
miR-134-5p inhibition reversed the effect of TDRKH-AS1 knockdown on cell proliferation and invasion. A, B CCK-8 and colony formation assays were used to determine the effect of partial reversal of miR-134-5p inhibitor on the proliferation ability of Si-TDRKH-AS1 in BC cells. C, D Wound healing and Transwell assays were performed to evaluate the effect of partial reversal of miR-134-5p inhibitor on the migration and invasion of Si-TDRKH-AS1 in BC cells. ∗P < 0.05; ∗∗P < 0.01